William R. Jacobs Jr., Ph.D.

Microbiology & Immunology

Phone718-678-1075
Emailwilliam.jacobs@einsteinmed.org
Websitehttp://www.einstein.yu.edu/faculty/6703/william-jacobs-jr/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where William R. Jacobs Jr. is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

3 Active
14 Finished

TB Phage therapy: Optimizing delivery methods of mycobacteriophages to target intracellular Mycobacterium tuberculosis
Jacobs Jr., W. R.
National Institute of Allergy and Infectious Diseases
12/7/20 → 11/30/21
Project: Research project
Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis
Jacobs Jr., W. R.
9/14/17 → 8/31/21
Project: Research project
MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS
Jacobs Jr., W. R., Jacobs Jr., W. R., Rose, S. A. & Rose, S. A.
12/31/89 → 8/31/21
Project: Research project
Shortening Tuberculosis Chemotherapies using N-acetylcysteine
Jacobs Jr., W. R.
6/15/18 → 5/31/20
Project: Research project
Reporter Phages for Diagnosis of Drug-Resistant TB in HIV High-Burden Populations
Jacobs Jr., W. R. & Rose, S. A.
8/15/13 → 3/16/15
Project: Research project

33691 Citations
101 h-Index
348 Article
14 Review article
9 Letter
8 Comment/debate
More

Sterilization by adaptive immunity of a conditionally persistent mutant of mycobacterium tuberculosis
Vilchèze, C., Porcelli, S. A., Chan, J. & Jacobs, W. R., Jan 1 2021, In: mBio. 12, 1, p. 1-5 5 p., e02391-20.
Research output: Contribution to journal › Article › peer-review

Open Access
3-(Phenethylamino)demethyl(oxy)aaptamine as an anti-dormant mycobacterial substance: Isolation, evaluation and total synthesis
Sumii, Y., Kotoku, N., Han, C., Kamiya, K., Setiawan, A., Vilchèze, C., Jacobs, W. R. & Arai, M., May 28 2020, In: Tetrahedron Letters. 61, 22, 151924.
Research output: Contribution to journal › Article › peer-review
A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, ΔgD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus
Ramsey, N. L. M., Visciano, M., Hunte, R., Loh, L. N., Burn Aschner, C., Jacobs, W. R. & Herold, B. C., Jun 16 2020, In: Journal of virology. 94, 13
Research output: Contribution to journal › Article › peer-review
2 Scopus citations
BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis
Tiwari, S., Dutt, T. S., Chen, B., Chen, M., Kim, J., Dai, A. Z., Lukose, R., Shanley, C., Fox, A., Karger, B. R., Porcelli, S. A., Chan, J., Podell, B. K., Obregon-Henao, A., Orme, I. M., Jacobs, W. R. & Henao-Tamayo, M., Oct 21 2020, In: Vaccine. 38, 45, p. 7156-7165 10 p.
Research output: Contribution to journal › Article › peer-review
Characterization of large deletion mutants of mycobacterium tuberculosis selected for isoniazid resistance
Vilchèze, C., Saranathan, R., Weinrick, B. & Jacobs, W. R., Sep 2020, In: Antimicrobial agents and chemotherapy. 64, 9, e00792-20.
Research output: Contribution to journal › Article › peer-review